126 related articles for article (PubMed ID: 898533)
1. An historical view of the medical-social aspects of the UGDP.
Knowles HC
Trans Am Clin Climatol Assoc; 1977; 88():150-6. PubMed ID: 898533
[No Abstract] [Full Text] [Related]
2. [University Group Diabetes Program. The UGDP investigation remains clinically unacceptable].
Aarseth S
Tidsskr Nor Laegeforen; 1976 Aug; 96(22):1148. PubMed ID: 951693
[No Abstract] [Full Text] [Related]
3. The UGDP--tolbutamide and mortality.
Knowles HC
Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
[No Abstract] [Full Text] [Related]
4. Audit confirms conclusions of UGDP study on oral diabetes drugs.
FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34-6. PubMed ID: 720789
[No Abstract] [Full Text] [Related]
5. Comments on the UGDP study.
Schöffling K
Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
[No Abstract] [Full Text] [Related]
6. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
Teuscher A
Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
[No Abstract] [Full Text] [Related]
7. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
Pirart J
Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
[No Abstract] [Full Text] [Related]
8. Editorials: Statistical problems in clinical trials: the UGDP study revisited.
Schor SS
Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989
[No Abstract] [Full Text] [Related]
9. The UGDP study.
Salsburg DS
JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
[No Abstract] [Full Text] [Related]
10. Misunderstanding or error? The UGDP report after four years.
Marigo S; Adezati L; Burnetti P; Pozza G; Robba L; Urbinati G
Acta Diabetol Lat; 1974; 11(5):357-422. PubMed ID: 4156992
[No Abstract] [Full Text] [Related]
11. Oral diabetic drugs again held hazardous.
J Tenn Med Assoc; 1975 Apr; 68(4):343. PubMed ID: 1117724
[No Abstract] [Full Text] [Related]
12. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
[No Abstract] [Full Text] [Related]
13. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
[No Abstract] [Full Text] [Related]
14. Editorial: Oral hypoglycemic drugs.
Scoville AB
J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
[No Abstract] [Full Text] [Related]
15. [Oral therapy in diabetes].
Kirkeby K
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1620-1. PubMed ID: 4588817
[No Abstract] [Full Text] [Related]
16. [Should the prescription of oral antidiabetic drugs be more limited? Results from controlled clinical trials].
Folling I
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1604-6. PubMed ID: 4769481
[No Abstract] [Full Text] [Related]
17. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
Seltzer HS
Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
[No Abstract] [Full Text] [Related]
18. [Heart death and oral antidiabetics; the last judgement].
Touber JL
Ned Tijdschr Geneeskd; 1975 Sep; 119(39):1506-8. PubMed ID: 1101083
[No Abstract] [Full Text] [Related]
19. [Tolbutamide and coronary heart disease].
Paasikivi J
Duodecim; 1971; 87(21):1405-8. PubMed ID: 5114598
[No Abstract] [Full Text] [Related]
20. [Considerations on diabetic angiopathies. Relations to hypoglycemic treatments].
Lubetzki J
Nouv Presse Med; 1972 Mar; 1(11):715-8. PubMed ID: 5022249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
